Previous section Next section
The interconversion stage of the pentose phosphate pathway
Body_ID: HC011020
Body_ID: P011040
Body_ID: F011009
Figure 11.9 The redox stage of the pentose phosphate pathway. A sequence of three enzymes forms 2 moles of NADPH per mole of Glc-6-P, which is converted into ribulose-5-phosphate, with evolution of CO2.
page 151
0
page 152
Body_ID: P0152
Body_ID: P011041
Body_ID: F011010
Figure 11.10 The interconversion stage of the pentose phosphate pathway. The carbon skeletons of three molecules of ribulose-5-phosphate are shuffled to form two molecules of Fru-6-P and one molecule of glyceraldehyde 3-phosphate.
Body_ID: T011002
Table 11-2. Summary of equilibrium reactions in the Pentose Phosphate Pathway.
Body_ID: None
The Pentose Phosphate Pathway
Body_ID: T011002.50
Substrate(s) Product(s)Enzyme
Body_ID: T011002.100
Ribulose-5-PRibose-5-Pisomerase
Body_ID: T011002.150
2 Ribulose-5-P2 Xylulose-5-Pepimerase
Body_ID: T011002.200
Xylulose-5-PGlyceraldehyde-3-Ptransketolase
Body_ID: T011002.250
+ Ribose-5-P + Sedoheptulose-7-P 
Body_ID: T011002.300
Sedoheptulose-7-PErythrose-4-Ptransaldolase
Body_ID: T011002.350
+ Glyceraldehyde-3-P+ Fructose-6-P 
Body_ID: T011002.400
Xylulose-5-PGlyceraldehyde-3-Ptransketolase
Body_ID: T011002.450
+ Erythrose-4-P + Fructose-6-P 
Body_ID: T011002.500
3 Ribulose-5-PGlyceraldehyde-3-P 
Body_ID: T011002.550
  + 2 Fructose-6-P 
Body_ID: T011002.600
Body_ID: T011002
Body_ID: None
In cells with active nucleic acid synthesis, ribulose-5-phosphate is isomerized to ribose-5-phosphate for synthesis of ribo- and deoxyribo-nucleotides for RNA and DNA (Fig. 11.10). In non-dividing cells, the pentose phosphates are routed back to glycolysis. This is accomplished by a series of equilibrium reactions in which 3 moles of ribulose-5-phosphate are converted into 2 moles of Fru-6-P and 1 mole of glyceraldehyde-3-phosphate. Certain restrictions are imposed on the interconversion reactions - they may be carried out only by transfer of two or three carbon units between sugar phosphates. Each reaction must also involve a ketose donor and an aldose receptor. Isomerases and epimerases provide the five-carbon aldose and ketose phosphate substrates for the interconversion stage. Transketolase, a thiamine-dependent enzyme, catalyzes the two-carbon transfer reactions. Transaldolase acts similarly to the aldolase in glycolysis, except that the three-carbon unit is transferred to another sugar, rather than released as a free triose phosphate into the cytoplasm.
Body_ID: P011039
As shown in Figure 11.10 and Table 11.2, two molecules of ribulose 5-phosphate, the first pentose product of the redox stage, are converted into separate products: one molecule is isomerized to the aldose sugar, ribose-5-phosphate, and the other is epimerized to xylulose-5-phosphate. Transketolase then catalyzes transfer of two carbons from xylulose-5-phosphate to ribose-5-phosphate, yielding a seven-carbon ketose sugar, sedoheptulose-7-phosphate, and the three-carbon glyceraldehyde-3-phosphate. Transaldolase then catalyzes a three-carbon transfer between the two transketolase products, from sedoheptulose-7-phosphate to glyceraldehyde-3-phosphate, yielding the first glycolytic intermediate, Fru-6-P, and a residual erythrose-4-phosphate. A second molecule of xylulose-5-phosphate donates two carbons to erythrose-4-phosphate in a second transketolase reaction, yielding a second molecule of Fru-6-P and a molecule of glyceraldehyde-3-phosphate, both of which enter glycolysis.
Body_ID: P011042
Thus, the three five-carbon sugar phosphates formed in the redox stage of the pentose phosphate pathway are converted into one three-carbon and two six-carbon glycolytic intermediates. In the RBC, these glycolytic intermediates normally continue through glycolysis to lactate, illustrating that glucoseView drug information is only temporarily shunted away from the mainstream of glycolysis.
Body_ID: P011043
page 152
0
page 153
Body_ID: P0153
MEASUREMENT OF BLOOD GLUCOSEView drug information - REDUCING SUGAR ASSAYS
Body_ID: B011004
The original assays for blood glucoseView drug information measured the reducing activity of blood. These assays work because glucoseView drug information, at 5 mM concentration, is the major reducing substance in blood. The Fehling and Benedict assays use alkaline cupric salt solutions. With heating, the glucoseView drug information decomposes oxidatively, yielding a complex mixture of organic acids and aldehydes. Oxidation of the sugar reduces cupric ion (blue-green color) to cuprous ion (orange-red color) in solution. The color yield produced is directly proportional to the glucoseView drug information content of the sample. Reducing sugar assays do not distinguish between glucoseView drug information, fructose or galactose. In diseases of fructose and galactose metabolism, such as hereditary fructose intolerance of galactosemia (Chapter 25), these assays could yield positive results for high plasma and urinary sugars, creating the false impression of diabetes.
Body_ID: PB11005
Previous section
Bar end Bar end
Next section
Copyright © 2007 Elsevier Inc. All rights reserved. Read our Terms and Conditions of Use and our Privacy Policy.
For problems or suggestions concerning this service, please contact: studentconsult.help@elsevier.com